SML3898
P144 diammonium
≥95% (HPLC)
别名:
Disitertide diammonium, P144 diammonium, Peptide 144 diammonium, TSLDASIIWAMMQN diammonium, Thr-Ser-Leu-Asp-Ala-Ser-Ile-Ile-Trp-Ala-Met-Met-Gln-Asn diammonium
质量水平
方案
≥95% (HPLC)
表单
(Powder or Lyophilized powder or film)
储存条件
desiccated
颜色
white to off-white
储存温度
-10 to -25°C
相关类别
生化/生理作用
Human type 3 TGF-β receptor sequence-derived TGF-beta1 (TGF-β1) inhibitor that blocks TGF-β1-mediated responses in vitro and in vivo.
P144 (Disitertide) is a 14-aa peptide TGF-beta1 (TGF-β1) inhibitor whose sequence corresponds to aa731-744 of human type 3 TGF-β receptor (UniProt Q03167). P144 blocks TGF-β1 from binding the type 3 TGF-β receptor and inhibits TGF-β1-mediated responses in vitro (80% MV1Lu growth inhibition by 200 μg/mL P144 in the presence of 200 pg/mL human TGF-β1) and in vivo (57% inhibition of hepatic stellate cells (HSCs) activation in a rat model of CCl4 inhalation-induced cirrhosis/hepatic fibrosis; 70 μg P144/rat via q.o.d. i.p.).
P144 (Disitertide) is a 14-aa peptide TGF-beta1 (TGF-β1) inhibitor whose sequence corresponds to aa731-744 of human type 3 TGF-β receptor (UniProt Q03167). P144 blocks TGF-β1 from binding the type 3 TGF-β receptor and inhibits TGF-β1-mediated responses in vitro (80% MV1Lu growth inhibition by 200 μg/mL P144 in the presence of 200 pg/mL human TGF-β1) and in vivo (57% inhibition of hepatic stellate cells (HSCs) activation in a rat model of CCl4 inhalation-induced cirrhosis/hepatic fibrosis; 70 μg P144/rat via q.o.d. i.p.).
免责声明
Hygroscopic
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
新产品
此项目有
Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis
The Journal of Investigative Dermatology, 125(3), 450-455 (2005)
A synthetic peptide from transforming growth factor beta type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury
Cytokine, 22(1-2), 12-20 (2003)
Identification of peptide inhibitors of transforming growth factor beta 1 using a phage-displayed peptide library
Cytokine, 39(2), 106-115 (2007)
P144 a Transforming Growth Factor Beta Inhibitor Peptide, Generates Antifibrogenic Effects in a Radiotherapy Induced Fibrosis Model
Current Oncology (Toronto, Ont.), 29(4), 2650-2661 (2022)
Peptide inhibitors of transforming growth factor-beta enhance the efficacy of antitumor immunotherapy
International Journal of Cancer. Journal International Du Cancer, 125(11), 2614-2623 (2009)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持